Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2298152rdf:typepubmed:Citationlld:pubmed
pubmed-article:2298152lifeskim:mentionsumls-concept:C0447640lld:lifeskim
pubmed-article:2298152lifeskim:mentionsumls-concept:C0030095lld:lifeskim
pubmed-article:2298152lifeskim:mentionsumls-concept:C0032017lld:lifeskim
pubmed-article:2298152lifeskim:mentionsumls-concept:C0033374lld:lifeskim
pubmed-article:2298152lifeskim:mentionsumls-concept:C0205164lld:lifeskim
pubmed-article:2298152pubmed:issue2lld:pubmed
pubmed-article:2298152pubmed:dateCreated1990-3-5lld:pubmed
pubmed-article:2298152pubmed:abstractTextAlthough the posterior pituitary is known to contain the PRL releasing activity or factor (PRF), its chemical identification has been a matter of dispute. In the present study, we purified PRF in porcine posterior pituitary extracts to chemically determine the primary structure. PRF activity was assessed during purification by the release of immunoreactive PRL from superfused rat pituitary cells. Two hundred seventy porcine posterior pituitaries were boiled, homogenized, and extracted with 2 M acetic acid. The acid extract was precipitated with 67% acetone, and the supernatant was absorbed onto a C18 column. The column was eluted step-wise with 10, 20, 30, 40, 50, and 60% acetonitrile (CH3CN) in 0.1% trifluoroacetic acid (TFA). The greatest PRF activity was recovered in the 30% CH3CN/0.1% TFA fraction and was further purified by ion-exchange chromatography on SP-Sephadex, followed by gel-filtration on Sephadex G-50. The Sephadex G-50 fractions with major PRF activity were finally purified by two cycles of reverse phase HPLC, yielding a single peak of PRF. Amino acid, as well as sequence analyses, indicated that the highly purified PRF was oxytocin. Authentic oxytocin showed the same chromatographic behavior and biological activity as those of the isolated peptide. In another experiment, desalted crude extracts of rat and porcine posterior pituitary tissues were directly chromatographed by reverse phase HPLC, and each fraction was assayed for PRF activity. Only two areas showed PRF activity; the largest activity coeluted with oxytocin and the smaller one co-eluted with vasopressin. The fractions which coeluted with oxytocin also showed oxytocin immunoreactivity, as examined by RIA. The results clearly indicated that the major PRF in these posterior pituitary extracts was oxytocin.lld:pubmed
pubmed-article:2298152pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2298152pubmed:languageenglld:pubmed
pubmed-article:2298152pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2298152pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2298152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2298152pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2298152pubmed:statusMEDLINElld:pubmed
pubmed-article:2298152pubmed:monthFeblld:pubmed
pubmed-article:2298152pubmed:issn0013-7227lld:pubmed
pubmed-article:2298152pubmed:authorpubmed-author:ArimuraAAlld:pubmed
pubmed-article:2298152pubmed:authorpubmed-author:OkaSSlld:pubmed
pubmed-article:2298152pubmed:authorpubmed-author:MoriMMlld:pubmed
pubmed-article:2298152pubmed:authorpubmed-author:VighSSlld:pubmed
pubmed-article:2298152pubmed:authorpubmed-author:MiyataAAlld:pubmed
pubmed-article:2298152pubmed:authorpubmed-author:YoshiharaTTlld:pubmed
pubmed-article:2298152pubmed:issnTypePrintlld:pubmed
pubmed-article:2298152pubmed:volume126lld:pubmed
pubmed-article:2298152pubmed:ownerNLMlld:pubmed
pubmed-article:2298152pubmed:authorsCompleteYlld:pubmed
pubmed-article:2298152pubmed:pagination1009-13lld:pubmed
pubmed-article:2298152pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:meshHeadingpubmed-meshheading:2298152-...lld:pubmed
pubmed-article:2298152pubmed:year1990lld:pubmed
pubmed-article:2298152pubmed:articleTitleOxytocin is the major prolactin releasing factor in the posterior pituitary.lld:pubmed
pubmed-article:2298152pubmed:affiliationU.S.-Japan Biomedical Research Laboratories, Tulane University Hebert Center, Belle Chasse, Louisiana 70037.lld:pubmed
pubmed-article:2298152pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2298152pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2298152pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2298152lld:pubmed